These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14691397)

  • 21. Intraocular pressure response to medication in a clinical setting: the Marshfield Clinic Personalized Medicine Research Project.
    McCarty CA; Mukesh BN; Kitchner TE; Hubbard WC; Wilke RA; Burmester JK; Patchett RB
    J Glaucoma; 2008 Aug; 17(5):372-7. PubMed ID: 18703947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving compliance with glaucoma eye-drop treatment.
    Cooper J
    Nurs Times; 1996 Aug 7-13; 92(32):36-7. PubMed ID: 8826416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glaucoma care and clinical profile in Priest Hospital, Thailand.
    Sothornwit N; Jenchitr W; Pongprayoon C
    J Med Assoc Thai; 2008; 91 Suppl 1():S111-8. PubMed ID: 18672602
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relevance of quality of life and treatment compliance measurement in patients with chronic open-angle glaucoma].
    Baudouin C; Béchetoille A; Bron A; Denis P; Nordmann JP; Renard JP; Rouland JF; Sellem E; Rigeade MC; Arnould B
    J Fr Ophtalmol; 2000 Dec; 23(10):1057-64. PubMed ID: 11139707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acceptance of own disease by patients with diagnosed glaucoma].
    Karna-Matyjaszek U; Sierzantowicz R; Mariak Z
    Pol Merkur Lekarski; 2010 Jan; 28(163):37-41. PubMed ID: 20369722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study.
    Friedman DS; Hahn SR; Gelb L; Tan J; Shah SN; Kim EE; Zimmerman TJ; Quigley HA
    Ophthalmology; 2008 Aug; 115(8):1320-7, 1327.e1-3. PubMed ID: 18321582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors associated with undiagnosed open-angle glaucoma: the Thessaloniki Eye Study.
    Topouzis F; Coleman AL; Harris A; Koskosas A; Founti P; Gong G; Yu F; Anastasopoulos E; Pappas T; Wilson MR
    Am J Ophthalmol; 2008 Feb; 145(2):327-335. PubMed ID: 18045565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antiglaucoma drugs--content of preservatives and the patient's compliance].
    Výborný P; Sejcková L
    Cesk Slov Oftalmol; 2006 Jul; 62(4):270-2, 274. PubMed ID: 16895060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of written instructions on accuracy of self-reporting medication regimen in glaucoma patients.
    Kharod BV; Johnson PB; Nesti HA; Rhee DJ
    J Glaucoma; 2006 Jun; 15(3):244-7. PubMed ID: 16778648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doctor-patient communication in glaucoma care: analysis of videotaped encounters in community-based office practice.
    Friedman DS; Hahn SR; Quigley HA; Kotak S; Kim E; Onofrey M; Eagan C; Mardekian J
    Ophthalmology; 2009 Dec; 116(12):2277-85.e1-3. PubMed ID: 19744715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of latanoprost and dorzolamide in the treatment of patients with open angle glaucoma.
    Niazi MK; Raja N
    J Ayub Med Coll Abbottabad; 2004; 16(1):50-3. PubMed ID: 15125183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study.
    Gieser DK; Tracy Williams R; O'Connell W; Pasquale LR; Rosenthal BP; Walt JG; Katz LM; Siegartel LR; Wang L; Rosenblatt LC; Stern LS; Doyle JJ
    J Glaucoma; 2006 Oct; 15(5):419-25. PubMed ID: 16988605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of adherence to glaucoma medical therapy in a long-term patient population.
    Djafari F; Lesk MR; Harasymowycz PJ; Desjardins D; Lachaine J
    J Glaucoma; 2009 Mar; 18(3):238-43. PubMed ID: 19295380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL; Friedman DS; Mozaffari E; Quigley HA; Walker AM
    Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the role of travoprost 0.004% ophthalmic solution in the management of open angle glaucoma and ocular hypertensive patients.
    Chiselită D;
    Oftalmologia; 2007; 51(2):81-6. PubMed ID: 17937041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma.
    Fontana H; Nouri-Mahdavi K; Lumba J; Ralli M; Caprioli J
    Ophthalmology; 2006 Jun; 113(6):930-6. PubMed ID: 16647135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucoma.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Nakahiro RK; Gill MA
    Clin Ther; 1991; 13(3):396-400. PubMed ID: 1954641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rates of glaucoma medication utilization among persons with primary open-angle glaucoma, 1992 to 2002.
    Stein JD; Ayyagari P; Sloan FA; Lee PP
    Ophthalmology; 2008 Aug; 115(8):1315-9, 1319.e1. PubMed ID: 18321581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depressive symptomatology, medication persistence, and associated healthcare costs in older adults with glaucoma.
    Jayawant SS; Bhosle MJ; Anderson RT; Balkrishnan R
    J Glaucoma; 2007 Sep; 16(6):513-20. PubMed ID: 17873711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study.
    Reis R; dos Santos LC; Vila MP; Magacho L
    Clin Ther; 2004 Dec; 26(12):2121-7. PubMed ID: 15823775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.